Expression profiling identifies responder and non‐responder phenotypes to interferon‐β in multiple sclerosis

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2000 • 9,712 citations

Axonal Transection in the Lesions of Multiple Sclerosis

1998 • 4,007 citations

Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

2000 • 3,258 citations

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

1996 • 2,410 citations

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1998 • 2,049 citations

Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosis

1995 • 1,903 citations

Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays

1998 • 1,781 citations

TNF neutralization in MS

1999 • 968 citations

Interferon beta‐lb in the treatment of multiple sclerosis

1995 • 899 citations

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1991 • 794 citations

Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

1998 • 601 citations

CD46 Is a Cellular Receptor for Human Herpesvirus 6

1999 • 518 citations

Interferon beta in the treatment of multiple sclerosis

1998 • 340 citations

The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis

1995 • 251 citations

Interferon beta induces interleukin‐10 expression: Relevance to multiple sclerosis

1996 • 240 citations

Multiple Sclerosis

1982 • 190 citations

Complex immunomodulatory effects of interferon‐β in multiple sclerosis include the upregulation of T helper 1‐associated marker genes

2001 • 179 citations

Genomic Views of the Immune System

2000 • 174 citations

Increases in soluble VCAM‐1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β‐1b

1997 • 155 citations

Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure

1997 • 124 citations

Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site.

1994 • 108 citations

IFN-β-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-β-1b Therapeutic Effects in Multiple Sclerosis

2000 • 107 citations

A comparative study of the relative bioavailability of different interferon beta preparations

2000 • 86 citations

Increased serum levels of soluble CD95 (APO‐1/Fas) in relapsing‐remitting multiple sclerosis

1998 • 72 citations

Immunotherapy of multiple sclerosis: Where are we? Where should we go?

2001 • 68 citations

Comparison of Gene Expression Patterns Induced by Treatment of Human Umbilical Vein Endothelial Cells with IFN-α2b vs. IFN-β1a: Understanding the Functional Relationship Between Distinct Type I Interferons That Act Through a Common Receptor

2002 • 66 citations

Interferon Beta in Multiple Sclerosis

1996 • 63 citations

Interferon-β treatment alters peripheral blood monocytes chemokine production in MS patients

2002 • 50 citations

Contrasting responses to interferon β-1b treatment in relapsing-remitting multiple sclerosis: Does baseline interleukin-12p35 messenger RNA predict the efficacy of treatment?

2000 • 39 citations

Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes

2002 • 35 citations

Interferon beta-1b treatment modulates TNFα and IFNγ spontaneous gene expression in MS

1999 • 33 citations

Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis.

2000 • 26 citations

Multiple sclerosis: Immunotherapy

1999 • 13 citations